Wave Life Sciences WVE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$26.09M+44.4% | -$53.18M— | -$53.85M+12.8% | -$50.47M-53.3% | -$46.88M-48.5% | ||
| $841K-3.9% | $844K-6.9% | $856K-9.7% | $865K-13.4% | $875K-16.0% | ||
| $9.06M+83.0% | $7.35M+127% | $6.47M+83.3% | $6.2M+77.8% | $4.95M+71.9% | ||
| -$1.28M+10.3% | -$8.72M— | $8.38M+750% | $1.62M— | -$1.42M+93.3% | ||
| $3.29M+260% | —— | —— | —— | -$2.05M-92.1% | ||
| -$13.52M-1.9% | $10.08M+45.2% | —— | —— | -$13.27M-30.0% | ||
| $751K+736% | —— | -$4.85M-103% | $199K+3,217% | -$118K-108% | ||
| -$28.25M-208% | -$5.97M+92.8% | —— | -$7.08M-10.6% | -$9.18M+26.8% | ||
| $4.83M+426% | —— | -$47K+97.0% | -$1.36M-235% | -$1.48M-221% | ||
| -$59.55M+5.5% | -$33.78M+22.6% | -$44.67M+3.9% | -$46.01M-67.5% | -$63.04M-88.6% | ||
| $438K+165% | $0-100% | $248K-35.2% | $306K+488% | $165K-60.4% | ||
| -$438K-165% | $0+100% | -$248K+35.2% | -$306K-488% | -$165K+60.4% | ||
| $1.93M-21.1% | $14.87M— | -$3.05M-102% | $594K— | $2.45M-82.5% | ||
| $2.53M-39.2% | $439.7M+1,157% | $32.69M-84.0% | $11.69M+1,691% | $4.16M-71.4% | ||
| -$4K-107% | —— | —— | $43K+153% | $58K+178% | ||
| -$57.47M+2.6% | $405.86M— | -$12.25M-108% | -$34.58M-28.3% | -$58.99M-204% | ||
| $9.06M+83.0% | $7.35M+127% | $6.47M+83.3% | $6.2M+77.8% | $4.95M+71.9% | ||
| $1.46M+13.6% | $1.42M+13.5% | $1.37M+13.6% | $1.33M+13.5% | $1.29M+13.6% | ||
| $841K-3.9% | $844K-6.9% | $856K-9.7% | $865K-13.4% | $875K-16.0% | ||
| -$13.52M-1.9% | $10.08M+45.2% | —— | —— | -$13.27M-30.0% | ||
| -$2.05M-13.6% | -$2.01M-13.6% | -$1.94M-13.7% | -$1.89M-13.8% | -$1.81M-14.0% | ||
| $751K+736% | —— | -$4.85M-103% | $199K+3,217% | -$118K-108% | ||
| $4.83M+426% | —— | -$47K+97.0% | -$1.36M-235% | -$1.48M-221% | ||
| $0-100% | $52.06M+923% | $30.21M+105% | $11.1M— | $1.26M— | ||
| $593K+34.2% | —— | $439K+41.6% | —— | $442K+26.6% | ||
| -$4K-107% | —— | —— | $43K+153% | $58K+178% | ||
| -$28.25M-208% | -$5.97M+92.8% | —— | -$7.08M-10.6% | -$9.18M+26.8% | ||
| -$59.99M+5.1% | -$33.78M+22.8% | -$44.91M+4.2% | -$46.32M-68.3% | -$63.2M-86.7% | ||
| -$59.99M+5.1% | -$33.78M+22.8% | -$44.91M+4.2% | -$46.32M-68.3% | -$63.2M-86.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Wave Life Sciences generate?
- Wave Life Sciences (WVE) generated -$184.0M in operating cash flow over the trailing twelve months.
- What is Wave Life Sciences's free cash flow?
- After $992.0K of capital expenditures, Wave Life Sciences's free cash flow was -$185.0M over the trailing twelve months, down 2.0% year over year.
- Where does Wave Life Sciences's cash flow data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
